|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Parvovirus B19 IgM ELISA | Amyloid Beta (1-42) ELISA Assay | Anti-Tocilizumab (Actemra®) ELISA | Cortisol (Free in Saliva) ELISA Assay | Gd-IgA1 (Galactose-deficient IgA1) ELISA |
| Citations | | | | | |
| Catalog Number | IB05002 | 27711 | TM09021 | IB79311 | 27600 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of human IgM antibodies directed against Parvovirus B19 in serum or plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Aß(1-42) in cerebrospinal fluid, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Tocilizumab (Actemra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of active free cortisol in saliva. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More |
| Detection Target | Parvovirus B19 IgM | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) | S100B | Human Undercarboxylated Osteocalcin (ucOC) | Metanephrine / Normetanephrine |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Serum and plasma. | Serum | Serum, plasma, tissue homogenates, and other biological fluids. | Urine |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 12.5 to 800 pg/mL | 0 / 6 to 200 ng/mL | 0.1 to 30.0 ng/mL | 1.56 to 100.0 ng/mL |
| Sensitivity | > 99% | 1 ng/mL | Inquire | 0.094 ng/mL | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | Overnight + 1 hr 30 mins (incubation) | 2 hours, 10 min. total incubation time. | 1 hr 30 mins (incubation) | 2 hours (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |